Clinical trial · Observational
Presentation of First Time Attenders at Lymphedema Clinics
Presentation of First Time Attenders at Lymphedema Clinics: Cross-sectional Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The first aim of this research project is to identify what factors motivate patients to seek assessment for early lymphedema and further, to gain insight into the signs and symptoms of developing lymphedema and the concurrent physical measurements. The second aim is to identify other sensory signs and symptoms and changes in body perception which may be perceived by the patient as reflective of lymphedema, and to identify to which degree they contribute to the patients' motivation to seek referral to lymphedema clinics.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Lymphedema | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Women with breast cancer-related lymphedema
- description
- Individuals with upper limb lymphedema developed after breast cancer treatment
- label
- Healthy control subjects
- description
- Healthy individuals without breast cancer-related lymphoedema.
Primary outcomes (3)
- measure
- Extracellular fluid in the arm
- timeFrame
- immediately after inclusion in the study
- description
- Bioimpedance spectroscopy (BIS) is a measurement tool used to determine the volume of extracellular fluid, of which lymph fluid is a component.
- measure
- Arm volume
- timeFrame
- immediately after inclusion in the study
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * women after breast cancer (\> 18 years) with unilateral axillary lymph node dissection or sentinel node biopsy; mastectomy (with or without autologous reconstruction) or wide excision of the tumor * able to give consent to participate in the research Exclusion Criteria: * patients under the age of 18 years
References
Publications (0)
Data not yet available